Related Experiment Video
Updated: Jun 13, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Postmenopausal hormones and sleep quality in the elderly: a population based study.
Gregory J Tranah1, Neeta Parimi, Terri Blackwell
1CPMC Research Institute, San Francisco, CA, USA. gtranah@sfcc-cpmc.net
Hormone therapy (HT) in postmenopausal women is linked to improved sleep quality, specifically shorter wake times after sleep onset and fewer long-wake episodes. However, potential vascular risks of HT should be carefully considered alongside these sleep benefits.
Area of Science:
- Gerontology
- Sleep Medicine
- Hormone Therapy Research
Background:
- Sleep disturbances are prevalent among postmenopausal women.
- The impact of hormone therapy (HT) on sleep in community-dwelling postmenopausal adults requires further investigation.
- This study examines the association between HT use and objectively measured sleep-wake patterns.
Purpose of the Study:
- To investigate the relationship between hormone therapy (HT) use and objective sleep parameters in postmenopausal women.
- To determine if current or past HT use influences sleep quality measures.
- To analyze sleep-wake data obtained via actigraphy in relation to HT status.
Main Methods:
- Utilized data from the Study of Osteoporotic Fractures (SOF) including 3,123 postmenopausal women (aged 77-99).
- Objective sleep-wake data were collected using wrist actigraphy for a mean of 4 consecutive days.
- Key sleep parameters included total sleep time, sleep efficiency (SE), sleep latency, wake after sleep onset (WASO), and nap time, adjusted for confounders.
Main Results:
- Current HT users exhibited significantly shorter WASO and fewer long-wake episodes compared to never users.
- Past HT users demonstrated longer total sleep time than never users.
- Women who never used HT had higher odds of poor sleep efficiency and significantly higher odds of prolonged WASO and frequent long-wake episodes compared to current HT users.
Conclusions:
- Current hormone therapy (HT) use in postmenopausal women is associated with improved objective sleep quality, specifically reduced WASO and fewer long-wake episodes.
- The underlying mechanisms for these observed sleep improvements with HT remain unclear.
- The decision to initiate HT in postmenopausal women necessitates a careful balance of potential sleep benefits against known vascular risks.
Related Concept Videos
Menopause
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Pharmacodynamics in Geriatric Patients: Effects of Age

